Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
87.3M
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
2.3M
-
Shares change
-
-13.9K
-
Total reported value, excl. options
-
$10.2M
-
Value change
-
-$15.6K
-
Number of buys
-
7
-
Number of sells
-
-5
-
Price
-
$4.43
Significant Holders of Immunome Inc. - COMMON STOCK (IMNM) as of Q3 2022
28 filings reported holding IMNM - Immunome Inc. - COMMON STOCK as of Q3 2022.
Immunome Inc. - COMMON STOCK (IMNM) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.3M shares
of 87.3M outstanding shares and own 2.64% of the company stock.
Largest 10 shareholders include Prentice Capital Management, LP (792K shares), Alpine Global Management, LLC (718K shares), VANGUARD GROUP INC (374K shares), GEODE CAPITAL MANAGEMENT, LLC (81.4K shares), Cerity Partners LLC (57K shares), BlackRock Inc. (41.5K shares), STATE STREET CORP (29.6K shares), ROYAL BANK OF CANADA (28.5K shares), Magnus Financial Group LLC (25.8K shares), and Baldwin Investment Management, LLC (25.4K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.